Leave Your Message

News

Kuvandudza Kubudirira kwePROTAC: Chidzidzo Chinoputsa

Kuvandudza Kubudirira kwePROTAC: Chidzidzo Chinoputsa

2024-07-04

Ongororo ichangoburwa muNature Communications inoratidza nzwisiso yakakosha mukati memukati mekusaina nzira dzinogadzirisa kushanda kwekwakanangwa kuderedzwa kweprotein uchishandisa PROTACs. Kuwanikwa uku kunogona kugadzira nzira yekurapa kwakanyanya kwegomarara nezvimwe zvirwere.

tarisa tsanangudzo
Kukurudzira Hutano uye Kupora: Kuchengeta Kwezuva Nezuva Kwevarwere veLeukemia

Kukurudzira Hutano uye Kupora: Kuchengeta Kwezuva Nezuva Kwevarwere veLeukemia

2024-07-03

Kuve nechokwadi chekuchengetedza uye kugadzika chiitiko chekurapa kwevarwere veleukemia kunosanganisira kungwarira kwezuva nezuva, kusanganisira hutsanana kwezvakatipoteredza, hutsanana hwemunhu, chikafu, uye kurovedza muviri kwakakodzera. Gwaro iri rinopa matipi akakosha ekutarisira kwakanaka kwezuva nezuva kutsigira kupora.

tarisa tsanangudzo
NS7CAR-T Cell Therapy Inoratidza Vimbiso Yekurapa R/R T-ALL/LBL

NS7CAR-T Cell Therapy Inoratidza Vimbiso Yekurapa R/R T-ALL/LBL

2024-06-20

Ongororo ichangoburwa inoratidza kushanda nekuchengetedzeka kweNS7CAR-T cell therapy mukurapa kudzokororwa kana refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) uye T-cell lymphoblastic lymphoma (R/R T-LBL). Kurapa uku kunopa tariro itsva kune varwere vane hutsinye mhando dzegomarara idzi.

tarisa tsanangudzo
Groundbreaking Mibairo yeCD7-Targeted CAR-T Therapy yeT-ALL neT-LBL

Groundbreaking Mibairo yeCD7-Targeted CAR-T Therapy yeT-ALL neT-LBL

2024-06-18

Ongororo ichangoburwa inoratidza mhedzisiro inovimbisa yeCD7-targeted chimeric antigen receptor (CAR) T cell therapy mukurapa varwere vane relapsed kana refractory T-cell acute lymphoblastic leukemia (T-ALL) uye T-cell lymphoblastic lymphoma (T-LBL).

tarisa tsanangudzo
Kuvharidzirwa kwe2024 ASH Musangano Wepagore uye Kuratidzwa

Kuvharidzirwa kwe2024 ASH Musangano Wepagore uye Kuratidzwa

2024-06-13

Musangano Wepagore wechimakumi matanhatu nenhanhatu weAmerican Society of Hematology (ASH) uchaitwa kubva muna Zvita 7-10, 2024, paSan Diego Convention Center, ichiratidza tsvakiridzo yepasi uye kufambira mberi muhematology.

tarisa tsanangudzo
Kuzivisa iyo 2024 Yegore Lu Daopei Hematology Forum muna Nyamavhuvhu

Kuzivisa iyo 2024 Yegore Lu Daopei Hematology Forum muna Nyamavhuvhu

2024-06-11

Musangano wechigumi nembiri weLu Daopei Hematology Forum wakarongwa kuti uitwe muna Nyamavhuvhu 23-24, 2024, paBeijing International Convention Center. Joinha isu panhaurirano dzine hungwaru uye kufambira mberi kwazvino muhematology.

tarisa tsanangudzo
Tariro Itsva muCancer Kurapa: TILs Therapy Inobuda seInotevera Frontier

Tariro Itsva muCancer Kurapa: TILs Therapy Inobuda seInotevera Frontier

2024-06-05

Pasinei nematambudziko arikuenderera mberi mumaindasitiri nekutengeserana, zvipimo zveCAR-T kurapwa zviri kugadziriswa nenzira itsva inovimbisa: Tumor-Infiltrating Lymphocyte (TIL) therapy. Kubudirira uku kunozivisa nguva itsva mukurwisa mamota akasimba.

tarisa tsanangudzo

Ko Maserura Therapies Ndiwo Remangwana reAutoimmune Disease?

2024-04-30

Kurapa kwechimurenga kwegomarara kunogona zvakare kurapa nekugadzirisa zvakare immune system kuti ipe kuregererwa kwenguva refu kana kurapa zvimwe zvirwere zve autoimmune.

tarisa tsanangudzo
2023 ASH Kuvhura | Dr. Peihua Lu Anopa CAR-T yeKudzokazve /Refractory AML Research

2023 ASH Kuvhura | Dr. Peihua Lu Anopa CAR-T yeKudzokazve /Refractory AML Research

2024-04-09
Chikamu chekutanga chekiriniki yeCD7 CAR-T yeR/R AML nechikwata chaDaopei Lu chakatanga kuASHMusangano wepagore wechi65 weAmerican Society of Hematology (ASH) wakaitwa pasina Indaneti (San Diego, USA) uye paIndaneti musi wa9-12 Zvita. , 2023.Vadzidzi vedu vakaita chiratidziro chikuru cheiyi co...
tarisa tsanangudzo
ASH 2023|"Izwi raLu Daopei" rinoimba panhandare yepasi rose

ASH 2023|"Izwi raLu Daopei" rinoimba panhandare yepasi rose

2024-04-09
IAmerican Society of Hematology (ASH) ndiyo musangano wepamusoro wezvidzidzo mumunda wehematology pasi rese. Nyaya yekuti Chipatara cheLu Daopei chakasarudzwa semufainari weASH kwemakore akatevedzana chinoratidza zvizere kubudirira kwayo muzvidzidzo muf...
tarisa tsanangudzo
ASH Voice of China| Muzvinafundo Xian Zhang: Kushanda Kwepamusoro uye Kuchengetedzeka kweNanobody Based Anti-BCMA CAR-T Therapy mukurapa Varwere Nekudzokerazve kana Refractory Multiple Myeloma.

ASH Voice of China| Muzvinafundo Xian Zhang: Kushanda Kwepamusoro uye Kuchengetedzeka kweNanobody Based Anti-BCMA CAR-T Therapy mukurapa Varwere Nekudzokerazve kana Refractory Multiple Myeloma.

2024-04-09
Musangano Wepagore wechi65 weAmerican Society of Hematology (ASH) wakaitwa kubva musi wa9 kusvika 12 Zvita 2023, muSan Diego, USA. Sechiitiko chikuru chepasirese uye chakazara chehematology chepamusoro chedzidzo chiitiko, chinokwezva zviuru zvenyanzvi nenyanzvi kubva kwese...
tarisa tsanangudzo